Eleven mutual funds were added in December to the list of approved instruments eligible to receive allocations from Chilean Pension Managers (AFPs). Of those, eight are domiciled in Luxembourg, two in Ireland and one in the USA.
CCR Monthly Approval Report – November 2015
Santander and Amundi registered four and three mutual funds in the month, respectively, while five other managers also won approval for one product of their own.
CCR Monthly Approval Report – October 2015
While WisdomTree and iShares led with three and two ETFs, respectively, registered in the month, Franklin Templeton, PineBridge and JP Morgan also won approval for funds of their own.
CCR Monthly Approval Report – September 2015
AXA and Fidelity registered six new mutual funds, while Nordea had three new funds approved.
CCR Monthly Approval Report – August 2015
While Edmond de Rothschild led with four mutual funds registered in the month, Neuberger Berman and Santander also won approval for two products of their own.
CCR Monthly Approval Report – July 2015
A global ETF brand registered nine new ETFs in the month, all of them UCITs products, while Invesco, F&C, Goldman Sachs and Van Eck each won approval for one of their own.
CCR Monthly Approval Report – June 2015
BlackRock registered six new iShares ETFs and four mutual funds, while JP Morgan and Principal each had two new funds approved.
CCR Monthly Approval Report – May 2015
May was a very active month for the Comisión Clasificadora de Riesgo, with 20 mutual funds added to the list and 27 products delisted. Candriam led with 11 funds registered in the month, while Pictet and Mirae each won approval for two of their mutual funds.
CCR Monthly Approval Report – April 2015
While Franklin Templeton and iShares led with nine mutual funds and 10 ETFs, respectively, registered in the month, Allianz, HSBC, Bluebay, NN IM, Pimco and Vanguard also won approval for products of their own.
CCR Monthly Approval Report – March 2015
While Vanguard led with six ETFs registered in the month, all of them UCITs products, BlackRock and Morgan Stanley each won approval for three of their mutual funds.